NS 580Alternative Names: NS580
Latest Information Update: 24 Nov 2015
At a glance
- Originator Nippon Shinyaku
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Endometriosis
Most Recent Events
- 24 Nov 2015 Phase-I clinical trials in Endometriosis in Japan (unspecified route)